Carvedilol phosphate

磷酸卡维地洛

Report date: 2025/07/27 20:00:07
NME

Base Information

Drug NameCarvedilol phosphate
Drug Alias NameCoreg Cr
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsBeta-1 adrenergic receptor antagonists
TargetsAdrenergic receptors alpha-1Beta-1 adrenergic receptor
Therapy Area/IndicationsCocaine-Related DisordersHypertensionVentricular Dysfunction, Left +[6] 
Global Approved IndicationsHypertensionVentricular Dysfunction, LeftHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/10/20
Country/TerritoryCanadaUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesWaylis Therapeutics LLC
Inactive CompaniesUtah State UniversityGlaxosmithkline PlcActavis Inc +[10] 
Active IndicationsHypertensionVentricular Dysfunction, LeftHeart Failure
Inactive IndicationsCocaine-Related DisordersHypertrophy, Left VentricularHeart Diseases

Other Information

ATC CodeC07AG02
Related LinksWikipediaDrugBankKEGG